Source: Psychopharmacology. Unidade: FM
Assunto: PSIQUIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WETZEL, H et al. Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology: a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. Psychopharmacology, v. 137, n. 03, p. 223-232, 1998Tradução . . Disponível em: https://doi.org/10.1007/s002130050614. Acesso em: 16 set. 2024.APA
Wetzel, H., Gründer, G., Hillert, A., Philipp, M., Gattaz, W. F., Sauer, H., et al. (1998). Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology: a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. Psychopharmacology, 137( 03), 223-232. doi:10.1007/s002130050614NLM
Wetzel H, Gründer G, Hillert A, Philipp M, Gattaz WF, Sauer H, Adler G, Schröder J, Rein W, Benkert O. Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology: a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist [Internet]. Psychopharmacology. 1998 ; 137( 03): 223-232.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s002130050614Vancouver
Wetzel H, Gründer G, Hillert A, Philipp M, Gattaz WF, Sauer H, Adler G, Schröder J, Rein W, Benkert O. Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology: a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist [Internet]. Psychopharmacology. 1998 ; 137( 03): 223-232.[citado 2024 set. 16 ] Available from: https://doi.org/10.1007/s002130050614
